The majority of Teva's business lies in generic and off-patent branded drugs and faces price and volume pressures that will be exacerbated as regulatory actions and other players in the drug supply ...
The global biohacking market size was US$ 19.5 billion in 2021. The global biohacking market size is forecast to reach US$ 54.8 billion by 2030, growing at a compound annual growth rate (CAGR) of 17.5 ...